About Dylan Sammut
Articles Written by Dylan Sammut
Nestle Health Science Strikes New Multibillion Deal
Nestle Health Science, a global business unit of Nestle S.A. (SWX: NESN), has announced a takeover of California-based Aimmune Therapeutics, Inc. (NASDAQ: AIMT) valued at $2.6 billion. Aimmune Therapeutics is a biopharmaceutical company developing and commercializing... Read More »
Health Care M&A Deals, August 28, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date... Read More »
QIAGEN Pushes On After Thermo Fisher Walks Away
In early March, Thermo Fisher Scientific Inc. (NYSE: TMO) announced a takeover QIAGEN N.V. (NYSE: QGEN) for $11.5 billion, or $43.64 per share in cash. The offer seemed high enough, as the target company only generated revenues of $1.53 billion in 2019, but the... Read More »
Vocera Adds New Patient Engagement Firm
Vocera Communications, Inc. (NYSE: VCRA), a mobile technology company serving the healthcare market, has expanded its patient engagement platform through a new acquisition. Last week, Vocera purchased a 100% interest in EASE Applications, LLC for $25 million in cash.... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
